Treatment with the SQ house dust mite sublingual immunotherapy tablet may be initiated year-round

J Allergy Clin Immunol Pract. 2018 Sep-Oct;6(5):1758-1760.e1. doi: 10.1016/j.jaip.2017.12.035. Epub 2018 Mar 1.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Dermatophagoides / immunology
  • Asthma / epidemiology
  • Asthma / immunology
  • Asthma / therapy*
  • Clinical Trials as Topic
  • Europe / epidemiology
  • Female
  • Humans
  • Hypersensitivity / epidemiology
  • Hypersensitivity / immunology
  • Hypersensitivity / therapy*
  • Male
  • North America / epidemiology
  • Pyroglyphidae / immunology
  • Seasons
  • Sublingual Immunotherapy / methods*
  • Tablets
  • Treatment Outcome

Substances

  • Antigens, Dermatophagoides
  • Tablets